-transparent.png){kind=logo}
Intraperitoneal injection of monosodium glutamate in neonatal rates resulted in a 90 percent loss of alpha-melanocyte-stimulating hormone in hypothalamic and extrahypothalamic areas of the brain, whereas the amount of hormone in the pituitary gland did not change. The dramatic reduction of alpha-melanocyte-stimulating hormone in the brain suggests that is primary source there is the neuronal perikarya of the arcuate nucleus.
Related Publications
R L Eskay, and
M J Brownstein, and
R T Long
June 2008,
Neuropeptides,
R L Eskay, and
M J Brownstein, and
R T Long
April 1978,
Endocrinology,
R L Eskay, and
M J Brownstein, and
R T Long
June 1978,
The Journal of investigative dermatology,
R L Eskay, and
M J Brownstein, and
R T Long
October 1992,
Neuropeptides,
R L Eskay, and
M J Brownstein, and
R T Long
March 1978,
Endocrinology,
R L Eskay, and
M J Brownstein, and
R T Long
January 1975,
Pharmacology, biochemistry, and behavior,
R L Eskay, and
M J Brownstein, and
R T Long
January 1985,
Peptides,
R L Eskay, and
M J Brownstein, and
R T Long
December 1978,
Proceedings of the National Academy of Sciences of the United States of America,
R L Eskay, and
M J Brownstein, and
R T Long
April 1989,
Experimental and clinical endocrinology,
R L Eskay, and
M J Brownstein, and
R T Long
June 1999,
Journal of neurotrauma,
